Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OASIS: SM-88 in HR+/HER2- Breast Cancer
NCT04720664Phase 2Terminated
- Sponsor
- Georgetown University
- Start
- Sep 2021
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of racemetyrosine in breast cancer, sponsored by Georgetown University. Started Sep 2021; status: terminated.
02
Drugs
racemetyrosine
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04720664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04720664.